Lamberto Landete

400 total citations
21 papers, 192 citations indexed

About

Lamberto Landete is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Lamberto Landete has authored 21 papers receiving a total of 192 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 9 papers in Neurology and 4 papers in Molecular Biology. Recurrent topics in Lamberto Landete's work include Multiple Sclerosis Research Studies (13 papers), Peripheral Neuropathies and Disorders (4 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). Lamberto Landete is often cited by papers focused on Multiple Sclerosis Research Studies (13 papers), Peripheral Neuropathies and Disorders (4 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). Lamberto Landete collaborates with scholars based in Spain and Canada. Lamberto Landete's co-authors include Aída Lago, Miguel Baquero, José Ignacio Tembl, Bonaventura Casanova, Francisco Coret, Isabel Boscá, C. Valero, Juan J. Vílchez, Ana Pascual and Francisco Pérez‐Miralles and has published in prestigious journals such as Stroke, Frontiers in Immunology and Journal of Neurology.

In The Last Decade

Lamberto Landete

13 papers receiving 186 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lamberto Landete Spain 6 76 63 59 36 33 21 192
Yolanda Bravo Spain 10 33 0.4× 180 2.9× 92 1.6× 73 2.0× 34 1.0× 13 404
Kazunori Akaji Japan 10 17 0.2× 31 0.5× 150 2.5× 46 1.3× 14 0.4× 31 334
Evgeny Sidorov United States 10 48 0.6× 73 1.2× 83 1.4× 24 0.7× 15 0.5× 22 229
Saadia Aidi Morocco 9 73 1.0× 29 0.5× 172 2.9× 56 1.6× 45 1.4× 20 317
A Lentini Italy 9 11 0.1× 79 1.3× 74 1.3× 77 2.1× 16 0.5× 21 238
Türkan Mete Türkiye 10 46 0.6× 14 0.2× 27 0.5× 39 1.1× 100 3.0× 22 261
J. Weaver United Kingdom 6 39 0.5× 28 0.4× 41 0.7× 8 0.2× 17 0.5× 11 414
Aikaterini Theodorou Greece 12 34 0.4× 163 2.6× 164 2.8× 57 1.6× 58 1.8× 68 387
J O Balzer Germany 6 15 0.2× 42 0.7× 137 2.3× 69 1.9× 26 0.8× 9 328
L Calandre Spain 10 28 0.4× 112 1.8× 149 2.5× 67 1.9× 13 0.4× 31 348

Countries citing papers authored by Lamberto Landete

Since Specialization
Citations

This map shows the geographic impact of Lamberto Landete's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lamberto Landete with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lamberto Landete more than expected).

Fields of papers citing papers by Lamberto Landete

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lamberto Landete. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lamberto Landete. The network helps show where Lamberto Landete may publish in the future.

Co-authorship network of co-authors of Lamberto Landete

This figure shows the co-authorship network connecting the top 25 collaborators of Lamberto Landete. A scholar is included among the top collaborators of Lamberto Landete based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lamberto Landete. Lamberto Landete is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brieva, Luís, Carmen Calles, Lamberto Landete, & Celia Oreja‐Guevara. (2025). Current challenges in secondary progressive multiple sclerosis: diagnosis, activity detection and treatment. Frontiers in Immunology. 16. 1543649–1543649.
2.
Monreal, Enric, Virginia Meca‐Lallana, Ana B. Caminero, et al.. (2025). Neurologists’ Openness to Evidence-Based Innovation in Multiple Sclerosis Care: Individual and Structural Determinants. Neuropsychiatric Disease and Treatment. Volume 21. 1523–1531.
3.
4.
García‐Domínguez, José Manuel, Jorge Mauriño, José Meca-Lallana, et al.. (2025). Attitudes of Neurologists Toward Serum Neurofilament Light-Chain Testing in the Management of Relapsing–Remitting Multiple Sclerosis with Cognitive Impairment. Journal of Personalized Medicine. 15(2). 69–69. 1 indexed citations
5.
Ochenduszko, Sebastián, et al.. (2024). Cytokine release syndrome and immune effector cell‑associated neurotoxicity syndrome in a melanoma patient treated with adjuvant pembrolizumab. Experimental and Therapeutic Medicine. 28(5). 423–423.
6.
Saposnik, Gustavo, Enric Monreal, Nicolás Medrano, et al.. (2024). Does serum neurofilament light chain measurement influence therapeutic decisions in multiple sclerosis?. Multiple Sclerosis and Related Disorders. 90. 105838–105838. 2 indexed citations
7.
Llufriú, Sara, Eduardo Agüera, Lucienne Costa‐Frossard, et al.. (2023). Recommendations for the coordination of Neurology and Neuroradiology Departments in the management of patients with multiple sclerosis. Neurología (English Edition). 38(7). 453–462.
8.
Alcalá, Carmen, Francisco Gascón, Ángel Pérez Sempere, et al.. (2022). Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study. Journal of Neurology. 269(7). 3676–3681. 12 indexed citations
9.
Landete, Lamberto, Francisco Pérez‐Miralles, Antonio Belenguer, et al.. (2021). Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain. Frontiers in Neurology. 12. 727586–727586. 5 indexed citations
10.
Llufriú, Sara, Eduardo Agüera, Lucienne Costa‐Frossard, et al.. (2021). Recomendaciones para la coordinación de los servicios de Neurología y Neurorradiología en la atención a pacientes con esclerosis múltiple. Neurología. 38(7). 453–462.
11.
12.
Coret, Francisco, et al.. (2010). Early diffuse demyelinating lesion in the cervical spinal cord predicts a worse prognosis in relapsing—remitting multiple sclerosis. Multiple Sclerosis Journal. 16(8). 935–941. 20 indexed citations
13.
Boscá, Isabel, et al.. (2008). Effect of relapses over early progression of disability in multiple sclerosis patients treated with beta-interferon. Multiple Sclerosis Journal. 14(5). 636–639. 18 indexed citations
14.
Casanova, Bonaventura, Francisco Coret, C. Valero, et al.. (2002). High clinical inflammatory activity prior to the development of secondary progression: a prospective 5-year follow-up study. Multiple Sclerosis Journal. 8(1_suppl). 59–63. 2 indexed citations
15.
Casanova, Bonaventura, Francisco Coret, C. Valero, et al.. (2002). High clinical inflammatory activity prior to the development of secondary progression: a prospective 5-year follow-up study. Multiple Sclerosis Journal. 8(1). 59–63. 9 indexed citations
16.
Casanova, Bonaventura, Francisco Coret, & Lamberto Landete. (2000). Estudio de diversas escalas de fatiga e impacto en la calidad de vida de los pacientes afectos de esclerosis múltiple. Revista de Neurología. 30(12). 1235–1235. 14 indexed citations
17.
Landete, Lamberto, et al.. (2000). Afectación axonal en la esclerosis múltiple. Conceptos actuales. Revista de Neurología. 30(10). 972–972.
18.
Landete, Lamberto, et al.. (1998). Síndrome de Sjögren y polirradiculopatía desmielinizante subaguda: una rara asociación. Revista de Neurología. 27(160). 995–995. 2 indexed citations
19.
Lago, Aída, et al.. (1998). Circadian Variation in Acute Ischemic Stroke. Stroke. 29(9). 1873–1875. 103 indexed citations
20.
Lago, Aída, et al.. (1998). Infarto lacunar y hemorragia cerebral profunda: comparación de factores de riesgo. Revista de Neurología. 27(158). 635–635. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yolanda Bravo Breakdown of academic impact, for papers by Kazunori Akaji Breakdown of academic impact, for papers by Evgeny Sidorov Breakdown of academic impact, for papers by Saadia Aidi Breakdown of academic impact, for papers by A Lentini Breakdown of academic impact, for papers by Türkan Mete Breakdown of academic impact, for papers by J. Weaver Breakdown of academic impact, for papers by Aikaterini Theodorou Breakdown of academic impact, for papers by J O Balzer Breakdown of academic impact, for papers by L Calandre
Rankless by CCL
2026